Charlotte's Web Holdings, Inc.’s CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences are collaborating to advance hemp cannabinoid science through a research program that provides a better understanding of the therapeutic uses and safety of cannabinoids.

This THC-free cannabinol (CBN) isolate is refined and purified through multi-phase distillation.

New research, published in the “Journal of Agricultural and Food Chemistry,” suggests a product’s matrix can impact a lab’s ability to precisely test for cannabinoid content.

Matthew Anderson, CEO of Vanguard Scientific, offered insights on the challenges cannabis ingredient suppliers and buyers face from seed to sale during Cannabis Products Exchange, held virtually July 30-31.

Radient Technologies Inc.'s Board of Directors is conducting a strategic review of the company’s operations, including management changes.

Willow Biosciences Inc. says it has successfully developed a scalable process for producing cannabigerol (CBG) with greater than 99 percent purity, no detectable THC and demonstrated production at 500-litre scale.

Through a proprietary process, Open Book Extracts is producing commercial quantities of bulk CBN at greater than 99 percent purity.

Demetrix Inc., a biotechnology company that makes safe and effective cannabinoids, has commenced 15,000-liter demo-scale fermentation production of the rare cannabinoid cannabigerol (CBG).